A propensity score–weighted study comparing a two- versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer

20223 citationsJournal Article

Authors

Good health and well-being

Published in: Breast Cancer Research and Treatment

Volume 198, Issue 1, pp. 23-29

Field-Weighted Citation Impact: 0.31